Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Is Dogecoin Price Attainable? Analysts Pick 3 Sub Tokens Likely to Lead The Charge
-
New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
-
Bitcoin Outlook for 2026: Can BTC Bounce Back in 2026? AI Predicts Remittix To Grow
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Hep B Free - Calls for Continued Universal Hepatitis B Birth-Dose Vaccination Despite Federal Advisory Shift
-
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
-
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
-
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
-
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
-
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
-
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
-
Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for November 2025
-
Mudcup 2025 (The Eighth Edition) Was A Smashing Success!
-
GJK Facilities Announces Scholarship to Support Aspiring Aerospace Engineer
-
Elysium Wealth Advisors Expands Services for Expatriates Across Europe
-
AMEEREX Signs MOU to Acquire 45.6 million-Ounce Silver-Gold Project in Nevada, Expanding Its North American Precious-Metals Portfolio
-
BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program
-
Roofing Expert Keith Miller Clarifies Why Flashing Is the Source of Many Roof Leaks in HelloNation
-
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
-
Worthington Steel Issues Statement Regarding Klöckner & Co SE
-
RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative
-
Watchung Hardscaping & Erosion Control: Retaining Wall Installations Announced
-
Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
-
Is Digitap ($TAP) Crypto Presale the Next Momentum Play?
-
Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
-
Digitap ($TAP) Volume Explodes in Final 24 Hours of Cyber Monday Sale
-
LiberNovo Goes Global: New Markets & A Vision for Healthy Workspaces
-
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
-
Ascent Solutions Appoints Previous Microsoft Sales Leader Jeff Mutschler as Senior Vice President of Alliances
-
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
-
Lordsbook Launches Its New App & Is Leading The Way To Christian Community & Discipleship
-
When to Choose Veneers vs. Partial Dentures
-
JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
-
JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
-
Vivacta Bio Announces Promising First-in-Human Results for GT801, an In Vivo CAR-T Therapy, in Non-Hodgkin's Lymphoma at the 2025 ASH Annual Meeting
-
Midwest MSP Titans of the Industry Recognizes GoTech IT Solutions as 2025 Awards Finalist
-
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
-
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
-
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at
-
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematolog
-
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
-
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
-
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
-
Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit
-
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
-
NMDP℠ Demonstrates Scientific Leadership in Expanding Patient Access to Lifesaving Cell Therapy at ASH 2025
-
Advances in Technology Help Improve Safety and Access to Blood Cancer Therapies
-
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
-
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist
